| PEB0178 | Associations of viremia and antiretroviral therapy duration with VIA positivity in Malawi: A retrospective analysis | E-poster | B17 |
| PEB0179 | Prevalence and predictors of hypertension stratified by HIV status in Kisumu, Kenya | E-poster | B18 |
| PEB0180 | Cardiovascular and metabolic comorbidities in HIV-infected patients in Colombia: A multicenter study | E-poster | B18 |
| PEB0181 | Patterns of antiretroviral use and immunologic correlates in the REPRIEVE trial at study entry | E-poster | B18 |
| PEB0182 | Increased epicardial adipose tissue volume in virally suppressed older HIV-infected Asian and Relationships to central fat accumulation and lipodystrophy | E-poster | B18 |
| PEB0183 | Increased IL1-β production during chronic HIV-infection; a role for innate reprogramming | E-poster | B18 |
| PEB0184 | Association of antiretroviral therapy with myocardial deformation in antiretroviral therapy-naive HIV-infected patients | E-poster | B18 |
| PEB0185 | Is hypertension more prevalent in HIV patients? A cross-sectional study from Rwanda | E-poster | B18 |
| PEB0186 | WHO HEARTS Treatment protocol facilitates integration of hypertension management into HIV care and improves blood pressure control at the largest HIV clinic in Uganda | E-poster | B18 |
| PEB0187 | Cardiovascular risk estimation is sub-optimal across two HIV cohorts | E-poster | B18 |